Skip to content

MOTION MEDICAL

Active
Private limited companyfounded 20188 yrs activeLindestraat 42, 1640 Sint-Genesius-Rode, BelgiumKBO/BCE: BE 0690.810.739
Summary

MOTION MEDICAL has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €3.59M and a net result of €323k. Equity remains stable across the filed fiscal years (±2.4% per year). Its solvency ranks better than 53% of 9038 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.7% (low).

Checked score

Score 2024
59 / 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. A confirmed filing finding caps the score. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability74▲+61
Solvency72▼-10
Growth32=
Track record100
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €210k at 30 days only on tighter terms
Liquidity ample (current ratio 2.09 against 2.4 in 2023; short-term debt: 45.3% and cash: 1.4% of total assets), but 53.1% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers risk+raises risk
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
46.9%
Return on assets
4.2%
Age of the figures
21 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 8 years 0 10 y
raises risk · Filed more than 90 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 31-10-2025, 92 days past the deadline. Measured on financial year 2023: companies more than 90 days late are in an abnormal legal state today in 5.61% of cases, against 1.66% across all filers.
NBB · 7 filings
Deviation from the deadline
2025
not confirmed
2024
92 d late
2023
27 d late
2022
4 d early
2021
27 d early
2020
19 d late
2019
8 d early
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, abbreviated schema

Equity
€3.59M▲ 9.9%
2023 · €3.27M
2019: €3.80M 2020: €3.99M 2021: €3.27M 2022: €3.53M 2023: €3.27M
2019 → 2024
Total assets
€7.65M▲ 33.2%
2023 · €5.74M
2019: €5.38M 2020: €5.70M 2021: €5.49M 2022: €5.49M 2023: €5.74M
2019 → 2024
Net result
€323k
2023 · €-265k
2019: €428k 2020: €207k 2021: €1.13M 2022: €744k 2023: €-265k
2019 → 2024
Working capital
€3.79M▲ 20.8%
2023 · €3.13M
2019: €3.50M 2020: €3.65M 2021: €2.86M 2022: €3.45M 2023: €3.13M
2019 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220232024Trend
Equity€3.99M-€3.27M▼ 17.9%€3.53M▲ 7.9%€3.27M▼ 7.5%€3.59M▲ 9.9%
Operating result€263k-€1.52M▲ 480%€951k▼ 37.6%€-279k€404k
Net result€207k-€1.13M▲ 444%€744k▼ 33.9%€-265k€323k
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€-500k€0€500k€1.00M€1.50MOperating result 2020: €263k€263kNet result 2020: €207k€207kOperating result 2021: €1.52M€1.52MNet result 2021: €1.13M€1.13MOperating result 2022: €951k€951kNet result 2022: €744k€744kOperating result 2023: €-279k€-279kNet result 2023: €-265k€-265kOperating result 2024: €404k€404kNet result 2024: €323k€323k20202021202220232024€-500k€0€500k€1MOperating result 2022: €951k€951kNet result 2022: €744k€744kOperating result 2023: €-279k€-279kNet result 2023: €-265k€-265kOperating result 2024: €404k€404kNet result 2024: €323k€323k202220232024
The operating result returns to profit in 2024: €404k after a loss of €279k in 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €7.65M
Fixed assets €395k ▲ 7.4%
Current assets €7.25M ▲ 35.0%
Equity and liabilities €7.65M
Equity €3.59M ▲ 9.9%
Debt €4.06M ▲ 64.1%
Debt's share of the balance-sheet total rises from 43.1% to 53.1%. Equity and debt are higher.
Key figures and ratios
2024 value · change against 2023
EBITDA
€482k
2023 · €-164k
Cash flow
€401k
2023 · €-151k
Current ratio
2.09
2023 · 2.40
Quick ratio
1.54
2023 · 1.73
Debt to equity
1.13
2023 · 0.76
ROE
9.0%
2023 · -8.1%
ROA
4.2%
2023 · -4.6%
Interest coverage
10.76
2023 · -2.81
Debt ≤ 1 year
€3.47M
2023 · €2.24M
Debt > 1 year
€550k
2023 · €213k
Income taxes
€37k
2023 · €-20k
Staff costs
€470k
2023 · €652k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 53 lines
Balance sheet Code20232024
Assets
Total assets20/58€5.74M€7.65M
Fixed assets21/28€368k€395k
Intangible fixed assets21€1k€21k
Tangible fixed assets22/27€113k€121k
Land and buildings22-€1k
Plant, machinery and equipment23€106k€91k
Furniture and vehicles24€3k€25k
Other tangible fixed assets26€3k€3k
Financial fixed assets28€253k€253k=
Current assets29/58€5.37M€7.25M
Stocks and contracts in progress3€1.51M€1.93M
Stocks30/36€1.51M€1.93M
Amounts receivable within one year40/41€3.57M€5.20M
Trade receivables40€790k€2.34M
Other amounts receivable41€2.78M€2.86M
Cash at bank and in hand54/58€271k€105k
Deferred charges and accrued income490/1€20k€17k
Equity and liabilities
Total equity and liabilities10/49€5.74M€7.65M
Equity10/15€3.27M€3.59M
Contributions10/11€1.00M€1.00M=
Reserves13€53k€53k=
Distributable reserves133€53k€53k=
Profit (loss) carried forward14€2.21M€2.53M
Amounts payable17/49€2.47M€4.06M
Amounts payable after more than one year17€213k€550k
Financial debts170/4€213k€550k
Amounts payable within one year42/48€2.24M€3.47M
Current portion of amounts payable after more than one year42€79k€241k
Financial debts43€502k€661k
Credit institutions430/8€502k€661k
Trade debts44€1.21M€2.43M
Suppliers440/4€1.21M€2.43M
Taxes, remuneration and social security45€449k€131k
Taxes450/3€315k€69k
Remuneration and social security454/9€134k€62k
Accrued charges and deferred income492/3€23k€43k
Income statement Code20232024
Remuneration, social security and pensions62€652k€470k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€114k€78k
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€3k€277k
Other operating charges640/8€7k€30
Gross operating margin9900€497k€1.23M
Operating profit (loss)9901€-279k€404k
Financial income75/76B€52k€485
Recurring financial income75€52k€485
Financial charges65/66B€58k€45k
Recurring financial charges65€58k€45k
Profit (loss) for the period before taxes9903€-285k€360k
Income taxes67/77€-20k€37k
Profit (loss) for the period9904€-265k€323k
Profit (loss) for the period to be appropriated9905€-265k€323k
Appropriation of the result
Profit (loss) to be appropriated9906€2.21M€2.53M
Profit (loss) brought forward from the previous period14P€2.48M€2.21M
Social balance
Average headcount (FTE)90877.37.4

The notes to these accounts (19 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
31-10
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema · 92 days late
2024
31-12
Financial Back to profitnet €323k
Net result €323k after one loss-making year.
27-08
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 27 days late
2023
31-12
Financial Weakest financial yearnet €-265k ▼136%
Net result drops to €-265k, the lowest in the series; recovery starts the following year.
27-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
04-07
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial Highest result since 2019net €1.13M ▲444%
Operating result €1.52M, net result €1.13M, both a record.
19-08
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 19 days late
2020
23-07
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
30-07
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Genesius-Rode · 1 establishment unit since 2018
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Lindestraat 421640 Sint-Genesius-Rode
Ground area
210 m²
Building footprint
89 m²
Volume, LiDAR
707 m³
Parcel 22004C0677/00T000, Flanders · tallest building 10.1 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
MOTION MEDICAL
Lindestraat 42, 1640 Sint-Genesius-RodeWholesale of pharmaceutical and medical goods
since 20182.273.423.048
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
22004C0677/00T000 Flanders 210 m² 1 · 89 m² 10.1 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Legal Entity Identifier

648864Y58M4CE8VPO938
live in the LEI register

Similar companies · same sector, comparable size

Of 1,898 companies in sector 46460 we hold annual accounts for 1,116. 627 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded21-02-2018
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
64210Activities of holding companies
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.